Home > Healthcare & Medical Devices > Skin Grafts Market
Skin Grafts Market Size is anticipated to record stellar progression from 2023 to 2032 due to the surging number of R&D investments and innovations in dermatomes.
In the recent past, the prominence of surgery has significantly soared as an effective treatment for skin loss resulting from various conditions. Hence, skin grafts are finding widespread adoption as they assist in enhancing the appearance of damaged skin, while replacing lost skin and restoring functions. The increasing demand for split-thickness and full-thickness skin grafts will also influence the product preference in the upcoming period.
The surging cases of burn injuries and skin infections mainly in North America and Europe will further drive the skin grafts market expansion. As per American Burn Association, over 400,000 people annually receive treatment for burn injuries. The increasing intervention of technological advancements in surgical procedures will also drive the need for skin grafts.
The emergence of the COVID-19 pandemic offered significant boost to the market outlook on account of the rising number of investments across the hospital outpatient as well as ambulatory surgical settings. However, the onset of the Russia-Ukraine war and the rising inflation rate worldwide may pose challenges to the revenue of the industry to some extent.
Based on graft thickness, the value for split-thickness skin grafts will gain substantial impetus through 2032 owing to their increasing importance in reconstructive ladder. Lately, healthcare organizations are increasingly preferring split-thickness solutions as they help cover large areas of missing or damaged skin. The increasing burden of skin loss driven by the rising prevalence of infection and reconstructive surgeries will further drive the product uptake.
In terms of application, the skin grafts market share from skin cancer will expand exponentially from 2023-2032. The growth can be ascribed to the rising advancements to cater to the soaring needs for skin cancer surgery. The thriving cases of skin cancer globally will also accelerate the adoption of skin grafts. As per the American Academy of Dermatology Association, nearly 9,500 people are diagnosed with skin cancer in the U.S. every day.
Regionally, North America skin grafts industry size is expected to record considerable traction through 2032 on account of the growing number of hospitals, dermatology clinics, and ambulatory surgical centers. The higher purchasing power and the thriving adoption of novel technologies have pushed several leading players in the region to expand their footprint. The increasing threat of burns wounds, and skin cancer in the U.S. and Canada will also support the regional expansion.
Some of the leading global skin grafts market are Zimmer Biomet, B. Braun Melsungen AG, Avita Medical, Integra Lifesciences Corporation, Surtex Instruments Limited, Nouvag AG, MiMedx, Organogenesis, Inc., De Soutter Medical Limited and Tissue Regenix, among others.